Covered recipient · General Payments record
NAOMI S WAAK
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$3,803.70
- Reported across 264 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $719.16 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $330.85 | 25 |
| Novo Nordisk AS | $155.53 | 17 |
| Takeda Pharmaceuticals U.S.A., Inc. | $40.17 | 2 |
| PFIZER INC. | $33.05 | 2 |
| ALK-Abello, Inc | $31.56 | 2 |
| GENZYME CORPORATION | $26.13 | 1 |
| Lilly USA, LLC | $22.90 | 1 |
| IBSA Pharma Inc. | $21.34 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $20.28 | 1 |
| GlaxoSmithKline, LLC. | $19.28 | 1 |
| Amgen Inc. | $18.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $6.64 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366848 | CMS |
| ABBVIE INC. | $20.59 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366850 | CMS |
| ABBVIE INC. | $19.94 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366852 | CMS |
| ABBVIE INC. | $4.02 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366854 | CMS |
| ABBVIE INC. | $9.40 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366856 | CMS |
| ABBVIE INC. | $8.99 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366858 | CMS |
| ABBVIE INC. | $14.73 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366860 | CMS |
| ABBVIE INC. | $26.57 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366862 | CMS |
| ABBVIE INC. | $3.13 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366864 | CMS |
| ABBVIE INC. | $34.04 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366866 | CMS |
| ABBVIE INC. | $20.03 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366868 | CMS |
| ABBVIE INC. | $8.39 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366870 | CMS |
| ABBVIE INC. | $17.29 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366872 | CMS |
| ABBVIE INC. | $2.00 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366874 | CMS |
| ABBVIE INC. | $11.56 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366876 | CMS |
| ABBVIE INC. | $25.77 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366878 | CMS |
| ABBVIE INC. | $16.83 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366880 | CMS |
| ABBVIE INC. | $6.80 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366882 | CMS |
| ABBVIE INC. | $16.95 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366884 | CMS |
| ABBVIE INC. | $7.74 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366886 | CMS |
| ABBVIE INC. | $7.17 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366888 | CMS |
| ABBVIE INC. | $7.57 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366890 | CMS |
| ABBVIE INC. | $15.27 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366892 | CMS |
| ABBVIE INC. | $6.34 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366894 | CMS |
| ABBVIE INC. | $13.09 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108366896 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $20.28 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147017259 | CMS |
| ALK-Abello, Inc | $14.05 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099896233 | CMS |
| ALK-Abello, Inc | $17.51 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099896235 | CMS |
| Amgen Inc. | $18.07 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117408677 | CMS |
| GENZYME CORPORATION | $26.13 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139823013 | CMS |
| GlaxoSmithKline, LLC. | $19.28 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116548585 | CMS |
| IBSA Pharma Inc. | $21.34 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142975948 | CMS |
| Lilly USA, LLC | $22.90 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135849754 | CMS |
| Novo Nordisk Inc | $3.70 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100510181 | CMS |
| Novo Nordisk Inc | $5.67 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100561521 | CMS |
| Novo Nordisk Inc | $4.91 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100337081 | CMS |
| Novo Nordisk Inc | $5.88 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100638690 | CMS |
| Novo Nordisk Inc | $5.55 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100246057 | CMS |
| Novo Nordisk Inc | $1.84 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100298505 | CMS |
| Novo Nordisk Inc | $22.19 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100578766 | CMS |
| Novo Nordisk Inc | $10.01 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100649467 | CMS |
| Novo Nordisk Inc | $5.89 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100268082 | CMS |
| Novo Nordisk Inc | $23.61 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100253866 | CMS |
| Novo Nordisk Inc | $5.96 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100630993 | CMS |
| Novo Nordisk Inc | $12.48 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100495157 | CMS |
| Novo Nordisk Inc | $8.82 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100628154 | CMS |
| Novo Nordisk Inc | $18.71 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100476798 | CMS |
| Novo Nordisk Inc | $5.00 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100446435 | CMS |
| Novo Nordisk Inc | $11.15 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100593116 | CMS |
| Novo Nordisk Inc | $4.16 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100292250 | CMS |
| PFIZER INC. | $14.69 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131115508 | CMS |
| PFIZER INC. | $18.36 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131254956 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.57 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137839569 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.60 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137839571 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.